Diet and Nutritional Interventions with the Special Role of Myo-Inositol in Gestational Diabetes Mellitus Management. An Evidence-Based Critical Appraisal


Reyes-Munoz E., Di Guardo F., Ciebiera M., Kahramanoglu I., Sathya-palan T., Lin L., ...More

CURRENT PHARMACEUTICAL DESIGN, vol.25, no.22, pp.2467-2473, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 25 Issue: 22
  • Publication Date: 2019
  • Doi Number: 10.2174/1381612825666190722155512
  • Title of Journal : CURRENT PHARMACEUTICAL DESIGN
  • Page Numbers: pp.2467-2473

Abstract

Background: Gestational Diabetes Mellitus (GDM), defined as glucose intolerance with onset or first recognition during pregnancy, represents one of the most common maternal-fetal complications during pregnancy and it is associated with poor perinatal outcomes. To date, GDM is a rising condition over the last decades coinciding with the ongoing epidemic of obesity and Type 2 Diabetes Mellitus (T2DM).